Form 4 for INCY Incyte
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-31 · accession 0000879169-25-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-01-31 | INCY | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +6,331 | 32.8K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | A | A | 6,331 | $0.00 | 32,778 | D | — | — | (F1) Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. (F2) Including the January 31, 2025 grant, this includes an aggregate of 32,778 shares of common stock issuable pursuant to previously reported RSUs that have not vested. |